• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
EfficacyIncluded studies
The evidence is inconclusive and so it is not possible to determine if there is a clinically important difference between BT + fluvoxamine and CT + fluvoxamine on the efficacy of treatment.VANBALKOM1998
Tolerability
The evidence is inconclusive and so it is not possible to determine if there is a clinically important difference between BT + fluvoxamine and CT + fluvoxamine on the likelihood of leaving the study early (K = 1; N = 52; RR = 0.86; 95% CI, 0.43 to 1.70). IVANBALKOM1998

From: 7, COMBINED INTERVENTIONS AND INTENSIVE INTERVENTIONS

Cover of Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder.
NICE Clinical Guidelines, No. 31.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2006.
Copyright © 2006, The British Psychological Society & The Royal College of Psychiatrists.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.